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Abstract 
 
Purpose: This systematic review and meta-analysis investigates bone mineral density (BMD) in individuals 
with anorexia nervosa (AN) and bulimia nervosa (BN) in comparison to healthy controls (HCs). AN has been 
associated with low BMD and a risk of fractures and mixed results have been obtained for the relationship 
between BN and BMD. Deciphering the effect these two ED subtypes on BMD will determine the effect of low 
body weight (a characteristic of AN) versus the effects of periods of restrictive eating and malnutrition which 
are common to both AN and BN.  
Methods: We conducted a systematic search through the electronic databases MedLine, EMBASE and 
PsychInfo and the Cochrane Library to investigate and quantify this relationship. We screened 544 articles and 
included 27 studies in a random-effects meta-analysis and calculated the standardised mean difference (SMD) in 
BMD between women with a current diagnosis of AN (n=785) vs HCs (979) and a current diagnosis of BN 
(n=187) vs HCs (350). The outcome measures investigated were spinal, hip, femoral neck and whole body 
BMD measured by DXA or DPA scanning. A meta-regression investigated the effect of factors including age, 
duration since diagnosis, duration of amenorrhea and BMI on BMD.  
Results: The mean BMI of participants was 16.65 kg/m² (AN), 21.16 kg/m² (BN) and 22.06 kg/m² (HC). Spine 
BMD was lowest in AN subjects (SMD, -3.681; 95% CI, -4.738, -2.625; p<0.0001), but also lower in BN 
subjects compared with HCs (SMD, -0.472; 95% CI, -0.688, -0.255; p<0.0001). Hip, whole body and femoral 
neck BMD were reduced to a statistically significant level in AN but not BN groups. The meta-regression was 
limited by the number of included studies and did not find any significant predictors. 
Conclusions: This meta-analysis confirms the association between low BMD and AN and presents a strong 
argument for assessing BMD not only in patients with AN, but also in patients with BN. 
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Introduction 
 
Osteoporosis is a condition that weakens bones and makes them prone to fractures. This disease affects almost 3 
million in the UK and is typically associated with advancing age (1). Excessive food restriction and malnutrition 
can lead to secondary osteoporosis and individuals with an eating disorder can present low BMD and 
osteoporosis at a young age (2, 3). The most studied eating disorders (EDs) in this field are anorexia nervosa 
(AN)  which includes a restricting and binge/ purge subtype and is primarily characterised by excessive food 
restriction and weight loss, and bulimia nervosa (BN), which is characterised by binge eating and compensatory 
purging behaviours (4, 5). There has been a recent increase in research to investigate the effect of AN diagnosis 
on BMD, but there have been no RCTs to date to determine the effect of a BN diagnosis on BMD and the 
development of osteoporosis in this group.   
 
Anorexia nervosa has been associated with low bone mineral density (BMD), impaired bone structure and an 
increased risk of bone fractures (6-10). Adolescent AN occurs at a critical time for bone mass acquisition, and 
limitations in bone accrual at this time can disrupt the attainment of peak bone mass and result in residual bone 
deficits despite recovery from AN (2, 11, 12). Peak bone mass is typically attained in the middle of the third 
decade of life and is a major determinant of fracture risk throughout life; individuals with adolescent onset AN 
have been found to not obtain optimal peak bone mass (13, 14). In contrast, individuals loose bone mass during 
adulthood may retain the ability to recover without residual bone deficits following complete weight gain, 
nutritional and menstrual recovery (15).  
 
Fractures are associated with significant pain, disability and loss of work days, and AN patients are 7 times 
more likely to have bone fractures than age-matched healthy women (16), with an estimated 90% having 
osteopenia and 40% having osteoporosis at one or more skeletal sites (17). Similar deficits have been reported in 
sufferers of BN, but studies have been limited by small sample sizes, inconsistent diagnostic criteria and 
comorbid psychiatric diagnoses of participants (18) which has made it impossible to determine the effect of BN 
on BMD. The extent to which bone metabolism is affected by malnutrition and weight loss may vary according 
to anatomical site, and some regions may be more prone to fractures than others (19). Disentangling the 
causative factors that lead to low bone density in the ED population is a fundamental step towards reducing 
fractures in this group. 
 
In contrast to AN, women with BN are usually at normal weight and many do not have  menstrual 
abnormalities, and thus studies have suggested that BMD in women with BN is comparable to that in healthy 
controls (20, 21) and that AN alone is associated with low bone mass (22-24). Others have suggested that 
although individuals with BN have higher BMD than those with AN, their BMD is lower than in healthy 
controls (20). Yet others have reported that BN, when coupled with low body weight and secondary 
amenorrhea, is a strong predictor of fracture risk and osteoporosis (25). A reduced BMD in BN compared to 
HCs may be associated with amenorrhea (20), low BMI (18) and a previous history of AN, but due to 
inconsistent methodologies in the available studies the relationship between BN and BMD is unclear.  
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In girls with AN, bone density measures are reported to be predicted positively by BMI, and inversely by loss of 
menses and duration of amenorrhea (26). The recovery of menses has been associated with a partial 
improvement in bone mass following recovery from an ED (27). Oestrogen therapy has been shown to increase 
BMD in post-menopausal women, in whom the hypo-estrogenic state otherwise results in significant bone loss. 
For this reason oral contraceptives have been widely used in patients with EDs. However, multiple studies have 
now shown that oestrogen given orally is not effective in increasing bone density in AN (28, 29). This is likely 
because of first pass hepatic metabolism resulting in a decrease in IGF-1, a key nutritionally regulated bone 
trophic hormone that is already low in AN. In contrast, transdermal oestrogen, which does not suppress IGF-1, 
does increase bone density in AN (13), although complete ‘catch up’ to a comparable BMD in healthy controls 
does not occur given that other hormonal deficits persist (27). 
 
Individuals with AN have been observed to have a lower bone mass than women with BN (30), which involves 
nutritional restriction but not necessarily a low body weight and amenorrhea, and also a lower bone mass than 
non-ED women with menstrual abnormalities and amenorrhea (17). Investigations into the causal mechanisms 
behind the low BMD in AN have thus far have focused on alterations in body composition, nutritional factors, 
and hormones (31-35). 
 
Current inconsistencies in the literature regarding bone consequences of AN vs BN and the role of age and the 
natural decline of BMD versus the duration and nature of the ED make it important to assess these knowledge 
gaps in a systematic fashion. Further, a thorough evaluation of the possible determinants of low bone density in 
patients with EDs, such as age, BMI, duration of amenorrhea and duration since diagnosis, is lacking and has 
never been studied using a meta-analysis. This systematic review and meta-analysis aims to investigate the 
relationship between AN, BN and BMD. If BMD is found to be reduced to a similar level in both AN and BN 
groups, then we may conclude that there are factors other than severe weight loss due to an ED (primarily seen 
in AN) which contribute to low BMD and secondary osteoporosis. This will be highly useful for informing 
treatment options for these groups which are currently lacking. 
 
The outcome measures investigated in this meta-analysis are spine, total, hip and femoral neck BMD. We have 
further investigated the influence of age, BMI, the presence of amenorrhea and the duration since diagnosis on 
bone mass in EDs.  
 
Materials and Methods  
 
Study Selection 
A search criterion was defined to extract research studies investigating the relationship between AN, BN and 
BMD. A literature search was conducted on bibliographic databases MedLine, EMBASE and PsychInfo and the 
Cochrane Library. Manual searches were conducted and reference lists were searched of included studies. 
Reviews on the topics of EDs and bone mineral density were searched to identify key themes and to inform 
search terms.  
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We conducted a search using combinations of search terms for eating disorders (Bulimia* Anorexia Nervosa* 
and Eating Disorders*) and for Osteoporosis we used (Osteoporosis*, Bone Loss *, Bone Density, Bone 
Mineral Density, Bone Mineral Content, Bone Mass, Fracture) the search was limited to publications in English. 
 
Published articles were eligible if they measured BMD using DXA or DPA scanning in subjects with a current 
ED, e.g. AN or BN, and a healthy control (HC) group. Participants with AN and a history of BN were excluded; 
however the BN group included participants with both a history of AN and with exclusively a BN diagnosis, 
which will later be divided into two sub-groups of BN. Participants identified to have an EDNOS (Eating 
disorder not otherwise specified) were excluded. Only studies which used female groups were included. We did 
not limit inclusion by study type, but in the cases of randomized controlled trials and longitudinal studies only 
baseline measures of BMD were used. When in doubt as to whether two studies had overlapping samples, we 
contacted the first author to ensure that no participants were used in multiple studies. Study eligibility was 
assessed by two authors (LR and NM) who discussed the inclusion criteria and reached a consensus based on 
the a priori criteria that studies report independent samples (no sample is used in multiple studies) of 
participants with either AN or BN and a corresponding healthy control group.  
 
The study selection included the initial screening of title and abstracts against the inclusion criteria using 
EndNote, and screening of full papers against the inclusion criteria. Studies fitting inclusion criteria were 
excluded for reasons including replication of participants from other included papers, or patients with AN or BN 
grouped with other ED participants. In the case of overlapping samples, only one study with the specific sample 
of participants could be included.  
 
Data Extraction 
Data were extracted from included papers using a standardized form. The following data were obtained from 
each study: Study name, year of publication, number of participants, number of participants with an ED 
(anorexic and bulimic subgroups), duration of disease, duration of amenorrhea, BMI, age, sample source, 
method of diagnosis, DXA or DPA scanning methods and BMD data for the spine, hip, femoral neck and whole 
body where available. Study characteristics including journal, source of funding, geographical location of study, 
ethnicity of participants, methods, primary outcome measures and key findings were also obtained from each 
study.  
 
Authors were contacted to retrieve data not published in several studies. Assessment of risk of bias did not 
justify exclusion of any further studies. The included studies were independently assessed by two reviewers (LR 
and NM) and any discrepancies in rating were discussed and resolved.  
 
Assessment of Risk of Bias 
Risk of bias was assessed using the Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised 
studies in meta-analyses. This scale assesses the selection of participants, the comparability of cases and 
controls and ascertainment of exposure. This includes definition of cases and controls, selection of controls and 
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representativeness of cases and the comparability of cases and controls. The exposure is assessed as the 
diagnosis of the ED and the bias of the sample through non-response rate.  
 
The Cochrane collaboration tool for assessing risk of bias was not appropriate as the studies were non-
randomised, but relevant aspects of this tool were considered including incomplete outcome data, selective 
outcome reporting and other potential sources of bias. All the included studies were considered to have a low 
risk of bias.  
 
Outcome Variables 
The outcomes of interest were spine, total, hip and femoral neck BMD.  
 
Statistical Analyses 
 
Meta-Analysis  
 
Statistical analysis was conducted using the STATA ‘metan’ command. The BMD, BMAD and aBMD values 
were entered for the AN groups, BN groups and control groups for the spine, hip, femoral neck and whole body 
(where available). Heterogeneity was suspected in the data and so a random effects meta-analysis was used (36).  
The standardized mean difference is used as a summary statistic in meta-analysis when the studies all assess the 
same outcome but measure it in a variety of ways and it is necessary to standardize the results of the studies to a 
uniform scale before they can be combined. The standardized mean difference expresses the size of the exposure 
effect in each study relative to the variability observed in that study (37).  
 
Meta-Regression 
 
We used a series of meta-regression analyses in STATA’s ‘metareg’ command to examine the effect of the 
studies’ sample characteristics on spine BMD. The predictors included: mean age, BMI and the duration since 
diagnosis (years). As different studies contained different predictors, the number of participants in each meta-
regression analysis varied. Due to the small number of studies which specified if subjects were of the diagnostic 
subtype of AN (restricting or binge/purge subtype), it was not possible to perform this subgroup analysis.  
 
Sensitivity Analyses 
 
Heterogeneity was suspected given the use of varying diagnostic tools, diagnostic crossover (between AN and 
BN), and lack of information on AN subtype in some studies (restricting/ binge-purging subtype). The 
heterogeneity in the data was assessed using Higgins I², and sensitivity analysis was conducted using the trim 
and fill analysis which aims both to identify and correct for funnel plot asymmetry arising from publication bias 
to determine if the removal of smaller studies would reduce publication bias (38). Eggers test for small study 
effects was conducted on spine, hip, femoral neck and whole body BMD data (39).  
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Results 
 
Search Results 
Twenty-five studies measuring BMD in AN, and six studies measuring BMD in BN met the inclusion criteria 
(Table 1). Four of these included both AN and BN subgroups. Figure 1 is a PRISMA diagram describing the 
search for eligible items (40). After searching electronic databases, 440 eligible articles were found, of which 
119 were identified as relevant based on the title and abstract. Additional searches were conducted based on 
reference lists and alternative search engines were used. A total of 41 studies met inclusion criteria, with 14 
excluded for factors such as replication of data, mixed ED group or for grouping participants with current and 
recovered EDs together. A total of 27 studies were included in the final meta-analysis.  
 
<Figure 1> 
 
Table 1 includes the 27 eligible studies that were conducted across 11 countries between 1990 and 2014. BMD 
was assessed in a total of 2359 participants, of which 972 had an ED (785 with AN and 187 with BN). The 
patients were all outpatients or patient referrals from clinics and all of the participants were female. Six studies 
assessed patients with BN, and four of these studies included BN participants with a history of AN. The mean 
age range was 15.9 – 34.3 years for AN studies, 22 – 27.7 years for BN studies and 15.1 – 37.4 years for HCs.   
 
All of the included studies used dual-energy X-ray absorptiometry (DXA) scanning (n=26) or dual photon 
absorptiometry scanning (DPA) (n=1) to measure BMD (also referred to in some studies as aBMD (areal Bone 
Mineral Density)), or used DXA measures to derive BMAD (bone mineral apparent density). Both DPA and 
DXA scanning have been found to have high clinical precision and accuracy (41). Two studies used both DXA 
and QCT (quantitative computed tomography) methods (42, 43), one used DXA and MRI (8), one used DXA 
and X-Ray (44) to assess bone health and one used DXA and CT (flat-panel volume computed tomography) 
scanning to assess bone strength (45). Only the DXA or DPA BMD or BMAD value was used in this meta-
analysis. Five studies assessed hormonal parameters in patients and controls by assessing biological 
concentrations of hormones (12, 13, 34, 46, 47), and one RCT assessed the effect of oestrogen administration on 
BMD in adolescent girls (48), but only the baseline BMD measures were included in the current meta-analysis. 
 
<Table 1> 
 
Diagnosis of an Eating Disorder 
All of the participants had been diagnosed with AN or BN by using the DSM-III, DSM-IV or ICD-10. All ED 
participants had been previously diagnosed by a health practitioner and referred to an eating disorder clinic 
where they were recruited, or their diagnosis was confirmed by a study psychiatrist. One study used a structured 
clinical interview (SCID) for diagnosis (49). The mean BMI (body mass index) of participants was 16.65 kg/m² 
(AN), 21.16 kg/m² (BN) and 22.06 kg/m² (HC). 
 
Selection of Controls 
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All of the controls used were normal weight and had no current or past history of EDs. Six studies used age-
matched controls, and two used age-matched and bone age-matched controls which is thought to more 
accurately isolate the effect of an ED on the bone in adolescent studies where girls of the same age could be at a 
considerably different stage of pubertal development (46, 50). All but nine controls had normal menstruation 
(51, 52) and all controls were recruited from the same geographical location as their corresponding ED 
participants. Studies recruited controls through community advertisements (n=5), advertisements across 
healthcare providers to patients and staff (n=7) and advertisements within universities to staff and students 
(n=4). The remaining studies did not give details of the recruitment of controls.  
 
Methodological Quality 
The Newcastle-Ottawa Scale (NOS) assessments of bias results are presented in Table 2. The general quality of 
the included studies in this meta-analysis was high, although the lowest scoring studies received only 2 out of 10 
stars. The mean score was 4.9* and the scores ranged from 2*-7*. A high quality rating depends on three 
characteristics: the selection of the study groups; the comparability of the groups; and the ascertainment of 
either the exposure or outcome of interest for case-control or cohort studies respectively.  There was generally 
adequate definition of cases and controls and the majority of studies reported a replicable and valid design and 
analysis. However, none of the studies reported drop-out or non-response rate and only 6 of the studies used the 
same method of ascertainment for cases and controls. The NOS assessment was not used as a tool for exclusion 
of studies in this meta-analysis. 
 
<Table 2> 
 
Meta-Analysis Results 
Compared with control participants, participants with either ED had an average SMD in spinal BMD of -2.955 
(p<0.0001). The results of the meta-analysis are presented in Table 3. 
 
 
Anorexia Nervosa 
The main outcome measure of spine BMD was lowest in subjects with AN. Further, BMD at all anatomical sites 
was significantly lower in the AN group (see Table 3). Spine BMD (SMD, -3.681; p<0.0001), hip BMD (SMD, 
-3.337; p<0.0001) and femoral neck BMD (SMD, -3.317; p<0.0001) showed the greatest difference, whereas 
whole body BMD (SMD, -1.782; p<0.0001) showed a smaller difference in AN. Figure 2 presents the SMD in 
AN studies which measure spinal BMD (a) and total BMD (b).  
 
Bulimia Nervosa 
The BMD is lower in the AN group than the BN group at every anatomical measure of BMD (Table 3). Spine 
BMD was still statistically significantly lower in the BN group than in healthy controls (SMD, -0.472; 
p<0.0001). Whole body BMD (SMD, -0.329; p=0.513) and femoral neck BMD (SMD, 0.211; p=0.463) were 
not significantly lower in the BN group than in healthy controls, although these analyses included few studies 
(four studies reported whole body BMD and only one study reported femoral neck BMD). No studies 
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investigated hip BMD in BN vs controls. Figure 3 presents the SMD in BN studies that measure spinal BMD (a) 
and total BMD (b).  
 
A post-hoc meta-analysis was run exclusively on the BN studies (n=6), and separated those studies with and 
without participants with a history of AN. Of the studies measuring BMD in BN participants, four included BN 
participants with a history of AN. BN participants with a history of AN (20, 22, 44, 53) had a significantly lower 
BMD than HCs (SMD, -0.521; p<0.0001). However, the groups including participants with BN and no history 
of AN (10, 23) did not have a significantly lower BMD than healthy controls (SMD, -0.339; p=0.108).  
 
<Table 3> 
 
<Table 4> 
 
Meta-Regression  
Table 4 presents the results of the meta-regression which investigated the effects of age, BMI and duration since 
diagnosis (years) on spinal BMD. The results were statistically non-significant in multiple linear meta-
regressions conducted on both AN and BN, although this was limited by the number of studies which could be 
included. Only 8 AN studies and 6 BN studies included data which could be used in the meta-regression.  
 
<Figure 2> 
 
<Figure 3> 
 
Sensitivity Analyses 
The Higgins I² heterogeneity statistic (98.3%) indicates that there is heterogeneity in the 27 studies measuring 
spine BMD. Publication bias is suspected in the analysis, as indicated by the funnel plot in Figure 3, and the 
Egger test (t=1.84; p<0.0001) performed on AN + BN participants’ spine BMD measures. The trim and fill 
correction for missing data was performed and the SMD was converted to an exponential form which remained 
significant (SMD, 0.052; p<0.0001). Karlsson (2000) and Seeman (1992) had particularly large effect sizes; 
when these two studies were removed from the analysis the SMD reduced and the confidence intervals 
narrowed (SMD, -2.019; p<0.0001), but the significant effect persisted. 
 
Discussion 
 
Low BMD in ED participants can lead to a high prevalence of bone fractures resulting in pain and disability; by 
disentangling the commonalities and differences between the effects of different ED diagnosis on BMD we have 
the potential to inform future treatment options in this group based on the overlapping characteristics of the ED 
subtypes. 
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We conducted a comprehensive meta-analysis to examine the relationship between EDs and BMD, consisting of 
two primary meta-analyses on AN groups versus healthy controls and BN groups versus healthy controls. The 
spinal BMD was statistically lower in the BN groups than healthy controls, but this effect was much smaller 
than in the AN groups. To investigate this result the BN groups were then separated into studies which included 
BN participants with a history of AN, and those studies with a criteria for BN with no history of other ED 
subtypes. Two further meta-analyses were conducted to investigate the spinal BMD in these BN subgroups 
versus healthy control groups.  
 
Previous research has consistently found a low BMD in participants with AN, but has failed to reliably 
determine the relationship between BN and BMD. Based on the current study results, there is evidence that 
patients with both AN and BN have lower spine BMD than healthy controls. We found on average a lower 
spinal BMD in the AN group than the BN group in comparison to healthy controls, but the effect of BN on 
spinal BMD was statistically significant. A number of factors were investigated to explain this relationship and 
the strongest predictor of a low spine BMD in the BN group was the inclusion of participants with a past history 
of AN in the sample. It is apparent that despite a BMI comparable to HCs, a history of AN was sufficient to 
produce a statistically significant lower BMD in the BN group, suggesting that acute malnutrition and weight 
loss can have long lasting and critical effects on the bone. 
 
Our findings support previous research which has found that 92% of patients with AN have BMD 1 SD below 
controls, and 38% patients have BMD 2.5 standard deviations below controls (17). We found that SMD between 
AN and controls was greatest for hip BMD and least for whole body BMD. Age and BMI were potentially 
stronger predictors of low BMD in participants with AN than in BN, although a small number of studies 
measuring each factor led to lack of power in these analyses and possibly accounted for non-significance of 
these associations in the meta-regression. Previous research has found age, BMI and both the duration of the ED 
and the duration of amenorrhea to be significant predictors of BMD in participants with AN (54, 55), and the 
limited number of studies and the limited number of variables which could be included in this meta-regression is 
likely to be the reason that we have not found similar results. We could not directly separate participants 
according to menstrual status in this meta-analysis, and cannot draw conclusions regarding the impact of 
menstrual status on BMD. 
 
Previous studies have found conflicting results regarding loss of BMD in patients with BN, some studies 
suggest that BN in combination with low body weight and amenorrhea is predictive of low BMD (20). In other 
studies, subgroup analysis determined that only those BN participants with a prior history of AN had lower 
spine BMD than healthy controls (20, 56). In our meta-regression, age, BMI and duration since diagnosis of the 
ED were not predictive of spine BMD in the BN group, and there were not enough studies measuring whole 
body and femoral neck BMD to conduct a meta-regression for these endpoints.  
 
We identified methodological issues in the studies included that may be important in the design of future 
studies, and these are useful in explaining the non-significant results of the meta-regressions. The majority of 
studies that we excluded from this meta-analysis failed to clearly define the ED diagnosis. Moreover, within 
12 
 
included studies, the wide ranges of age, BMI and illness duration in both subgroups meant that the mean values 
used in the meta-regression might not capture the large variability within studies.  Figure 2 indicates that 
Karlsson (2000) and Seeman (1992) are outliers in this analysis. Karlsson (2000) included participants who had 
exclusively received no treatment for their ED, and Seeman (1992) included participants who exclusively had 
secondary amenorrhea. The variability in characteristics of participants in this meta-analysis limits between-
group comparisons and may explain the heterogeneity in the data.  
 
Based on our quality analysis, the studies with the poorest quality assessment rating were limited in their 
elaboration of the representativeness of cases and controls, and particularly the ascertainment of disorder in 
cases. Variation in an ED diagnosis may account for the lack of predictors identified for spine BMD in either the 
AN or BN subgroups. The overall quality of the systematic review was high, meeting 25 of 27 criteria using 
PRISMA guidelines (57). Despite potential bias in studies included in this review, their results give a consistent 
representation of the relationship between an ED and BMD.  
 
A recent review on AN and bone loss by Misra (2014) reported that low BMD is a consequence of AN in both 
sexes and across a wide age range. Studies also suggest that bone health may not fully recover until weight has 
been regained (58) and normal nutritional status established (59), although the rate of recovery may vary 
according to the nature and duration of the ED and adolescents may show only partial ‘catch-up’ (60). However, 
this study found that despite a BMI similar to healthy controls, the BN sample had a significantly lower spinal 
BMD. This finding suggests that weight alone does not account for the difference in BMD, and the BN sample 
has other characteristics including a history of AN, perhaps relapses into AN and a continued poor nutritional 
status which may contribute to a lower BMD. These findings suggest that both AN and BN patients should be 
screened for low BMD with a DXA scan at an early age. 
 
Data are lacking regarding the magnitude of the difference in BMD when an ED begins in adolescence versus 
adulthood, and there are no longitudinal studies that have determined the long-term effects of adolescent onset 
ED on peak bone mass and BMD in adulthood.  The pattern of BMD loss in women with lifetime EDs is still 
unknown and longitudinal data are necessary to determine if BMD decreases at a consistent rate throughout life, 
or if there is a rapid decrease in the initial stages of an ED followed by low but stable BMD throughout life.  
 
Although recent studies have shown some evidence for a positive effect of estrogen replacement on bone loss in 
AN, given the limited treatment options, preventive methods are vital to reduce osteoporosis in this clinical 
group. This meta-analysis suggests that low BMD occurs in BN as well as AN. We propose that a multi-
dimensional approach is needed to fully understand the impact of an ED on BMD.  
 
Impaired nutrition, which causes changes in lean and fat mass and multiple hormonal alterations, contributes to 
impaired bone metabolism in AN (27). The strongest and most consistent predictor of an increase in BMD 
following recovery from AN is weight gain; however, no single body composition or hormonal factor can 
account for this improvement, which is typically incomplete in adolescents. BMD in AN is lower than that 
predicted by weight loss alone (61), suggesting that there is a cascade of events associated with increased energy 
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availability (including a normalization of hormone secretion and a positive effect on protein synthesis promoting 
bone remodelling) which may account for the lower BMD in both AN and BN women, suggesting that common 
methods of treatment should be used for both ED subtypes which focus on more than weight gain alone (62). 
 
Strengths and Limitations 
 
The objectivity of this meta-analysis is its main strength, provided by a quantitative measurement of BMD in 
different participant groups. Due to the small number of studies and the heterogeneity within these, it was not 
possible to make conclusions based on the meta-regression and it was thus difficult to measure trends in 
participant characteristics relating to the loss of BMD. Furthermore, due to the limited number of BN studies 
and the lack of adolescent BN participants, it was not possible to make inferences about bone accrual over time.  
 
The meta-analysis compares studies that measure BMD across four anatomical locations in AN participants, and 
two anatomical locations in BN participants. The varying loss of bone mass in different anatomical locations 
found in this study provides the foundation for future research to investigate which regions of the skeleton are 
most vulnerable to the effects of an ED, and factors such as exercise and nutrition that influence bone health.  
 
The significant association between BN and BMD is an important finding of this study, but the varying history 
of AN in several of the BN samples confounds this finding. This is both a strength and limitation of this meta-
analysis. It is beneficial to know that a history of AN puts women with BN at risk for secondary osteoporosis, 
however the ever-changing nature of psychiatric disorders, and particularly eating disorders, makes it 
problematic to study one condition in isolation. Thus the very low sample size of women exclusively with BN 
makes it difficult to determine the effect of BN with no history of AN on BMD.  
 
Finally, several studies report bias in the control groups, including self-selected controls for a study on energy 
expenditure (63) and for a fitness and dietary study (10). Furthermore, no studies in this meta-analysis screened 
the control groups using a structural clinical interview for DSM (SCID) (64). A meta-analysis of this kind relies 
on the accurate formulation of groups to enable optimal group comparisons, and bias in the control groups may 
influence the accuracy of results. 
 
 
Conclusion 
 
We found a significant reduction in BMD in both AN and BN ED subtypes. The greater reduction in BMD in 
the AN group suggests that characteristics particular to this disorder play a key role in the subsequent loss of 
bone mass. However, the reduced BMD in the BN group, despite a similar BMI to healthy controls, suggests 
that weight loss alone does not account for the low BMD in participants with an ED. Particular attention should 
be paid to adolescents with an ED, as loss of bone mass in adolescents may be to some extent irreversible. 
Future research should accurately determine the key correlates of bone loss and accordingly should develop a 
multifaceted and targeted treatment plan.  
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Ref. ED  Sample Size (n) Design ED Population  Controls Diagnostic Method Scanning Method Bone Density Outcome Measures 
Bredella (2008) AN 
HC 
10 
10 
Case control ED clinics 
 
Healthy Controls 
Clinic advertisements 
DSM-IV  DXA Spinal BMD 
Hip BMD 
Total BMD 
Bredella (2009) AN 
HC 
10 
10 
Case-control Clinic Referrals 
 
Healthy controls 
Recruited through community 
advertisements 
‘Psychiatric diagnostic 
criteria for AN’ 
DXA 
 
MRI 
Spinal BMD 
Hip BMD 
Total BMD 
Bredella (2012) AN 
HC 
10 
5 
Case-control  Clinic Referrals Healthy Controls. 
Recruited through community 
advertisements 
DSM-IV DXA 
Fluorodeoxyglucose-PET and 
CT 
Spinal BMD 
Hip BMD 
Total BMD 
Femoral neck BMD 
Lateral spine BMD 
Davies, K. M., et 
al. (1990).  
AN 
BN 
HC 
26 
11 
211 
Case-control Clinic records of eating 
disorder patients from 
medical centre 
Healthy controls  
Some self-select for fitness 
and diet study. Some DXA 
and DPA comparison group. 
DSM-III  
DSM-III-R 
DPA Spinal BMD  
Forearm BMD 
Faje (2013) AN 
HC 
44 
23 
Cohort Hospital outpatients Healthy Controls. 10-90th 
percentile normal weight. 
DSM-IV DXA Spinal aBMD 
Hip aBMD 
Distal Radius aBMD 
Fernandez-Soto 
(2009) 
AN 
HC 
31 
25 
Cohort Clinic outpatients Healthy Controls 
Caucasian women 
DSM-IV DXA Spinal BMD 
Total Body BMD 
Guo (2013) AN 
HC 
26 
24 
Cohort Clinic Psychiatrist 
referrals 
 
Healthy Controls 
Age-matched 
DSM-IV DXA 
 
Spinal  BMD 
Hip BMD 
Total BMD 
Iketani, T., et al. 
(1995).  
 
AN 
BN 
HC 
 
20 
10 
10 
Cohort Clinic inpatients and 
outpatients 
Healthy Controls 
Age matched healthy females.  
DSM-III-R DPA Spinal BMD 
Whole Body BMD 
Karlsson (2000) AN 
HC 
77 
205 
Case-Control AN Patients untreated with 
estrogen therapy  
Healthy Controls 
Regular menstrual cycles  
ICD-10 DXA Spinal BMD, aBMD and BMC 
Femoral neck  vBMD, aBMD and 
BMC  
Kooh (1996) AN 
HC 
22 
24 
Cohort Clinic referrals: 
Adolescent medicine clinic 
Healthy Controls 
School and university 
students. No oral 
contraceptives.  
DSM-III-R DXA Femoral neck  BMD 
Spinal  BMD 
Naessen, S., et 
al. (2006) 
BN 
HC 
77 
56 
Cohort Recruited from hospital 
advertisements 
Healthy Controls 
Hospital advertising: hospital 
staff and students. No current 
diseases or medication prior to 
3 months before study.  
  
DSM-IV DXA Total BMD 
Spinal BMD 
Leg BMD  
Table 1: Summary of Study Characteristics 
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Ref. ED  Sample Size (n) Design ED Population  Controls Diagnostic method Methods Bone Density Outcome Measures 
Newton, J., et al. 
(1993). 
BN 
HC 
20 
16 
Cohort ED outpatient treatment 
program. 
.  
Healthy Controls 
Age and sex matched controls 
from hospital staff 
noticeboards.  
DSM-IIIR 
SCID to assess past AN  
(64) 
DXA Spinal BMD 
Maimoun (2014) AN 
HC 
98 
63 
Case-control Hospital outpatients  Healthy Controls 
Community advertisement.  
DSM-IV  DXA Whole body  aBMD 
Spinal  aBMD 
Dominant arm radius  aBMD 
Total proximal femur  aBMD  
Masala (2003) AN 
HC 
17 
27 
Cohort Patients in weight gain 
program 
Healthy Controls 
Exclusion included 
medication or illness to affect 
bone 
ICD-10 DXA 
QCT 
Spinal BMD 
Misra (2005) AN 
HC 
23 
21 
Cohort Clinic Referrals Healthy Controls  
Age matched and bone age 
matched. 
Adverts through healthcare 
providers and newspapers 
DSM-IV  DXA Spinal BMAD 
Hip BMD 
Misra (2007) AN 
BN 
17 
19 
Cohort Paediatrician referrals  Healthy Controls 
Age matched and bone age 
matched. 
Mailings to paediatricians.  
DSM-IV  DXA 
 
Spinal BMAD 
Hip BMD 
Femoral neck BMAD 
Total Body BMD 
Total Body BMC 
Misra (2011) AN 
HC 
120 
40 
RCT Hospital outpatient 
treatment program 
Healthy Controls 
Mailings to paediatricians. 
DSM-IV  
 
 
DXA 
 
Spinal BMD 
Spinal BMAD 
Hip BMD 
Morris (2004) AN 
BN 
HC 
 
51 
26 
40 
 
Cohort ED specialist referrals  Control group data from 
department of medical physics  
DSM-IV  
 
 
DXA 
X-Ray 
Spinal BMD 
Whole Body BMD 
Olmos (2010) AN 
HC 
51 
40 
Prospective 
longitudinal cohort 
study.  
ED unit outpatients Healthy Controls 
Hospital advertisements 
DSM-IV  DXA Spinal BMD 
Femoral neck BMD 
Total Hip BMD 
Poet (1993) AN 
HC 
18 
36 
Cohort  Hospital outpatients Healthy Controls 
Volunteers  
DSM-III-R 
 
DXA Spinal BMD 
Resch (2000) AN 
HC 
 
 
 
 
20 
20 
 
Cohort Hospital outpatients Healthy Controls 
Age matched nursing school 
students.  
DSM-III-R DXA Spinal BMD 
Hip BMD 
20 
 
 
 
 
 
 
 
 
Ref. ED  Sample Size (n) Design ED Population  Controls Diagnostic method Methods Bone Density Outcome Measures 
Seeman (1992) AN 
HC 
65 
52 
Cohort Patients with AN Healthy Controls 
Volunteers with no illness that 
affects the bone. No drugs, 
medication. 
DSM-III-R DXA Spinal BMD 
Proximal femur BMD 
Femoral neck BMD 
Ward’s triangle BMD 
Trochanter BMD 
Soyka (1999) AN 
HC 
19 
19 
Cohort Healthcare provider 
referrals 
 
Healthy Controls 
Advertisement in primary care 
providers and newspapers. 
BMI 25th-90th centile. One 
pre-menarche.  
DSM-IV DXA Spinal BMD 
Spinal BMC 
Lateral spine BMD 
Total BMD 
Sundgot-Borgen, 
J., et al. (1998). 
AN 
BN 
HC 
13 
43 
17 
Case-control Clinic Referrals Healthy Controls 
University information board 
recruitment. Comprehensive 
inclusion criteria for dietary, 
exercise and ED symptoms.  
DSM-IV DXA Spinal BMD 
Total BMD 
Femoral Neck BMD 
Leg BMD 
Arm BMD 
van Marken 
(1997) 
AN 
HC 
12 
16 
 
Cohort Non-hospitalised 
outpatients.  
Healthy Controls 
Normal weight participating 
in a study on energy 
expenditure. 
DSM-III-R DXA Total BMD 
Total BMC 
Walsh (2010) AN 
HC 
8 
6 
Cohort Hospital outpatients Healthy Controls 
90-100% ideal weight for age.  
DSM-IV  DXA 
Flat-panel volume 
computed tomography (CT) 
Spinal BMD 
Hip BMD 
Femoral neck BMD 
Wojcik (2010) AN 
HC 
15 
16 
Cohort Healthcare referrals and 
community adverts 
Healthy Controls  
Community advertisement 
recruitment 
DSM-IV  DXA Spinal BMD 
Hip BMD 
Femoral neck BMD 
Total BMD 
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Table 2: Newcastle Ottawa Scale Results for Quality Assessment  
 
 
 
  
Ref. Selection Comparability Exposure Total 
Bredella 2012 *** * ** 6* 
Bredella 2008 **** ** ** 8* 
Bredella 2009 *** * * 5* 
Davies, K. M., et al. (1990). ***  * 4* 
Faje 2013 ** * * 4* 
Fernandez-Soto 2013 ** * * 4* 
Guo 2013 ** * ** 5* 
Iketani, T., et al. (1995). ** ** * 5* 
Karlsson 2000 ***  * 4* 
Kooh1996 ** * * 4* 
Masala 2003 *** * * 5* 
Misra 2005 *** ** * 6* 
Misra 2007 *** ** * 6* 
Misra 2011 ** * * 4* 
Maimoun 2014 **** * * 6* 
Morris 2004 ****  * 5* 
Naessen, S., et al. (2006) **  * 3* 
Newton, J., et al. (1993). **** ** * 7* 
Olmos2010 *** * * 5* 
Poet 1992 *** * * 5* 
Resch 2000 *** * * 5* 
Seeman 1992 *** * * 5* 
Soyka 1999 *** * * 5* 
Sundgot-Borgen, J., et al. (1998). **** ** * 7* 
Van Marken1997 **  * 3* 
Walsh 2010 ** * * 4* 
Wojkik2010 ** * * 4* 
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Table 3: Meta-Analysis Results  
 
 
 
 
 
Table 4: Meta-Regression Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anatomical Site N SMD L 95% CI U 95% CI Z      p 
AN only       
Spinal 22 -3.681 -4.738 -2.625 6.83 <0.0001 
Total 13 -1.782 -2.517 -1.047 4.75 <0.0001 
Hip 11 -3.337 -4.874 -1.799 4.25 <0.0001 
Femoral Neck 
 
11 -3.317 -5.151 -1.484 3.55 <0.0001 
All BN Studies       
Spinal 6 -0.472 -0.688 -0.255 4.28 <0.0001 
Total 4 -0.329 -0.573 -0.084 2.63 0.513 
       
BN w/o History of AN       
Spinal 2 -0.339     -0.753      0.075          1.61 0.108 
Total N/A      
       
BN & History  of AN       
Spinal 4 -0.521        -0.775 -0.268   4.03 <0.0001 
Total 3 -0.259       -0.529    0.011 1.88 0.060 
Covariate Coefficient L 95% CI U 95% CI p 
AN Studies  (N=8)     
Age -0.609 -2.976 1.757 0.514 
BMI 0.942   -2.234 4.118 0.457      
ED Duration 0.383 -3.246  4.012 0.784 
     
BN Studies (N=5)     
Age -0.007   -2.085    2.072 0.974     
BMI -0.070 -5.408     5.268 0.895     
ED Duration 0.076 0.633     -1.424   0.633     
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Figure Legends 
 
Figure 1: Meta-analysis search strategy. AN = anorexia nervosa, BN = Bulimia nervosa 
 
Figure 2: Spinal BMD in AN groups. _ES = effect size, _seES = standard error of effect size 
 
Figure 3: Spinal BMD in BN groups. _ES = effect size, _seES = standard error of effect size 
 
Table Footnotes 
 
Table 1: Study characteristics of included studies in the meta-analysis. PET = positron emission tomography , 
CT = computerised tomography. ‘Spinal’ refers to measurement of BMD at the lumbar spine. BMD = Bone 
Mineral Density, BMAD = Bone Mineral Apparent Density, aBMD = areal Bone Mineral Density. (n) = 
Number.   
 
Table 2: Quality Analysis of all included studies rated by two trained observers (LR) (VA).  
 
Table 3: Meta-Analysis Standardised Mean Differences and Confidence Intervals for the Anorexia Nervosa and 
Bulimia Nervosa Groups vs. Healthy Control Groups. N= Number, Z= Z-Scores, p= p-value, L= Lower, U = 
Upper. 
 
Table 4: Meta-Regression Results for the Covariates influencing the Spinal BMD in the Anorexia Nervosa and 
Bulimia Nervosa Groups. N= Number, p= p-value, L= Lower, U = Upper. 
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